C
Contineum Therapeutics Inc
NASDAQ:CTNM
Contineum Therapeutics Inc
NASDAQ:CTNM
Price:
15.27
USD
1.8%
Market Cap:
$445.6m
Cash Flow Statement
Cash Flow Statement
Contineum Therapeutics Inc
Contineum Therapeutics Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
14
|
5
|
(35)
|
(42)
|
(50)
|
(57)
|
(59)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
3
|
4
|
5
|
7
|
9
|
10
|
10
|
|
| Other Non-Cash Items |
(2)
|
(2)
|
2
|
4
|
6
|
8
|
9
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(1)
|
(0)
|
5
|
4
|
2
|
(2)
|
|
| Cash from Operating Activities |
11
N/A
|
3
-75%
|
(33)
N/A
|
(33)
+2%
|
(39)
-20%
|
(46)
-18%
|
(52)
-13%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(56)
|
(95)
|
(51)
|
(69)
|
(63)
|
(10)
|
35
|
|
| Cash from Investing Activities |
(57)
N/A
|
(96)
-68%
|
(51)
+46%
|
(70)
-36%
|
(64)
+9%
|
(11)
+83%
|
34
N/A
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
60
|
169
|
109
|
109
|
109
|
1
|
20
|
|
| Net Issuance of Debt |
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
56
N/A
|
165
+193%
|
108
-34%
|
109
+1%
|
109
+0%
|
1
-99%
|
20
+2 479%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
11
N/A
|
72
+570%
|
23
-67%
|
6
-73%
|
6
-3%
|
(56)
N/A
|
2
N/A
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
11
N/A
|
2
-80%
|
(34)
N/A
|
(33)
+2%
|
(40)
-19%
|
(47)
-18%
|
(53)
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
